AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis

References

• Gou Y, Yi J, Jiang M, Cao C. Analysis on effects of comprehensive nursing care applied in interventional therapy for patients with liver cirrhosis and liver cancer. Iran J Public Health. 2019;48(3):494–500.
   PubMed Web of Science ®Google Scholar
• Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182–188. doi:10.1111/his.13975
   PubMed Web of Science ®Google Scholar
• Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139–152. doi:10.1038/s41575-019-0229-4
   PubMed Web of Science ®Google Scholar
• Sagnelli E, Macera M, Russo A, Coppola N, Sagnelli C. Epidemiological and etiological variations in hepatocellular carcinoma. Infection. 2020;48(1):7–17. doi:10.1007/s15010-019-01345-y
   PubMed Web of Science ®Google Scholar
• Mandlik DS, Mandlik SK. Herbal and natural dietary products: upcoming therapeutic approach for prevention and treatment of hepatocellular carcinoma. Nutr Cancer. 2020;1–25. doi:10.1080/01635581.2020.1834591
   Web of Science ®Google Scholar
• Li L, Xu X, Wu L, et al. Scutellaria barbata polysaccharides inhibit tumor growth and affect the serum proteomic profiling of hepatoma H22 bearing mice. Mol Med Rep. 2019;19(3):2254–2262. doi:10.3892/mmr.2019.9862
   PubMed Web of Science ®Google Scholar
• Ma TT, Zhang GL, Dai CF, et al. Scutellaria barbata and Hedyotis diffusa herb pair for breast cancer treatment: potential mechanism based on network pharmacology. J Ethnopharmacol. 2020;259:112929. doi:10.1016/j.jep.2020.112929
   PubMed Web of Science ®Google Scholar
• Wang L, Xu J, Yan Y, et al. Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC-1). Artif Cells Nanomed Biotechnol. 2019;47(1):1617–1627. doi:10.1080/21691401.2019.1594862
   PubMed Web of Science ®Google Scholar
• Li H, Su J, Jiang J, et al. Characterization of polysaccharide from Scutellaria barbata and its antagonistic effect on the migration and invasion of HT-29 colorectal cancer cells induced by TGF-beta1. Int J Biol Macromol. 2019;131(48):886–895. doi:10.1016/j.ijbiomac.2019.03.053
   PubMed Web of Science ®Google Scholar
• Dai ZJ, Wu WY, Kang HF, et al. Protective effects of Scutellaria barbata against rat liver tumorigenesis. Asian Pac J Cancer Prev. 2013;14(1):261–265. doi:10.7314/APJCP.2013.14.1.261
   PubMedGoogle Scholar
• Hopkins AL. Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008;4(11):682–690. doi:10.1038/nchembio.118
   PubMed Web of Science ®Google Scholar
• Xing S, Wang Y, Hu K, et al. WGCNA reveals key gene modules regulated by the combined treatment of colon cancer with PHY906 and CPT11. Biosci Rep. 2020;40(9). doi:10.1042/BSR20200935.
   Web of Science ®Google Scholar
• Yang R, Du Y, Wang L, Chen Z, Liu X. Weighted gene co-expression network analysis identifies CCNA2 as a treatment target of prostate cancer through inhibiting cell cycle. J Cancer. 2020;11(5):1203–1211. doi:10.7150/jca.38173
   PubMed Web of Science ®Google Scholar
• Xue K, Cao J, Wang Y, et al. Identification of potential therapeutic gene markers in nasopharyngeal carcinoma based on bioinformatics analysis. Clin Transl Sci. 2020;13(2):265–274. doi:10.1111/cts.12690
   PubMed Web of Science ®Google Scholar
• Kumar S, Kaushik A, Narasimhan B, et al. Molecular docking, synthesis and biological significance of pyrimidine analogues as prospective antimicrobial and antiproliferative agents. BMC Chem. 2019;13(1):85. doi:10.1186/s13065-019-0601-z
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Lopes CT, Franz M, Kazi F, et al. Cytoscape web: an interactive web-based network browser. Bioinformatics. 2010;26(18):2347–2348. doi:10.1093/bioinformatics/btq430
   PubMed Web of Science ®Google Scholar
• Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. Bmc Syst Biol. 2014;8(Suppl 4):S11. doi:10.1186/1752-0509-8-S4-S11
   PubMed Web of Science ®Google Scholar
• Li C, Xu J. Feature selection with the Fisher score followed by the Maximal Clique Centrality algorithm can accurately identify the hub genes of hepatocellular carcinoma. Sci Rep. 2019;9(1):17283. doi:10.1038/s41598-019-53471-0
   PubMed Web of Science ®Google Scholar
• Zhang L, Ren B, Zhang J, et al. Anti-tumor effect of Scutellaria barbata D. Don extracts on ovarian cancer and its phytochemicals characterisation. J Ethnopharmacol. 2017;206:184–192. doi:10.1016/j.jep.2017.05.032
   PubMed Web of Science ®Google Scholar
• Dai ZJ, Wang BF, Lu WF, et al. Total flavonoids of Scutellaria barbata inhibit invasion of hepatocarcinoma via MMP/TIMP in vitro. Molecules. 2013;18(1):934–950. doi:10.3390/molecules18010934
   PubMed Web of Science ®Google Scholar
• Kan X, Zhang W, You R, et al. Scutellaria barbata D. Don extract inhibits the tumor growth through down-regulating of Treg cells and manipulating Th1/Th17 immune response in hepatoma H22-bearing mice. BMC Complement Altern Med. 2017;17(1):41. doi:10.1186/s12906-016-1551-9
   PubMed Web of Science ®Google Scholar
• Gong B, Kao Y, Zhang C, Sun F, Zhao H. Systematic investigation of Scutellariae barbatae herba for treating hepatocellular carcinoma based on network pharmacology. Evid Based Complement Alternat Med. 2018;2018:4365739. doi:10.1155/2018/4365739
   PubMed Web of Science ®Google Scholar
• Yasen M, Mizushima H, Mogushi K, et al. Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue. Cancer Sci. 2009;100(3):472–480. doi:10.1111/j.1349-7006.2008.01068.x
   PubMed Web of Science ®Google Scholar
• Cai C, Wang W, Tu Z. Aberrantly DNA methylated-differentially expressed genes and pathways in hepatocellular carcinoma. J Cancer. 2019;10(2):355–366. doi:10.7150/jca.27832
   PubMed Web of Science ®Google Scholar
• Sang L, Wang XM, Xu DY, Zhao WJ. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma. World J Gastroenterol. 2018;24(24):2605–2616. doi:10.3748/wjg.v24.i24.2605
   PubMed Web of Science ®Google Scholar
• Agarwal R, Narayan J, Bhattacharyya A, Saraswat M, Tomar AK. Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets. Cancer Genet. 2017;216–217:37–51. doi:10.1016/j.cancergen.2017.06.002
   PubMed Web of Science ®Google Scholar
• Bi N, Sun Y, Lei S, et al. Identification of 40S ribosomal protein S8 as a novel biomarker for alcohol associated hepatocellular carcinoma using weighted gene coexpression network analysis. Oncol Rep. 2020;44(2):611–627. doi:10.3892/or.2020.7634
   PubMed Web of Science ®Google Scholar
• Lin ZZ, Jeng YM, Hu FC, et al. Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B overexpression in HCC. Bmc Cancer. 2010;10:461.
   PubMed Web of Science ®Google Scholar
• Carmena M, Ruchaud S, Earnshaw WC. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins. Curr Opin Cell Biol. 2009;21(6):796–805. doi:10.1016/j.ceb.2009.09.008
   PubMed Web of Science ®Google Scholar
• Lens SM, Wolthuis RM, Klompmaker R, et al. Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 2003;22(12):2934–2947. doi:10.1093/emboj/cdg307
   PubMed Web of Science ®Google Scholar
• Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol. 2001;11(2):49–54. doi:10.1016/S0962-8924(00)01880-8
   PubMed Web of Science ®Google Scholar
• Adams RR, Wheatley SP, Gouldsworthy AM, et al. INCENP binds the Aurora-related kinase AIRK2 and is required to target it to chromosomes, the central spindle and cleavage furrow. Curr Biol. 2000;10(17):1075–1078. doi:10.1016/S0960-9822(00)00673-4
   PubMed Web of Science ®Google Scholar
• Chen L, Chao SB, Wang ZB, et al. Checkpoint kinase 1 is essential for meiotic cell cycle regulation in mouse oocytes. Cell Cycle. 2012;11(10):1948–1955. doi:10.4161/cc.20279
   PubMed Web of Science ®Google Scholar
• Tun JO, Salvador-Reyes LA, Velarde MC, et al. Synergistic cytotoxicity of renieramycin M and doxorubicin in MCF-7 breast cancer cells. Mar Drugs. 2019;17(9):536. doi:10.3390/md17090536
   PubMed Web of Science ®Google Scholar
• Gong D, Feng PC, Ke XF, et al. Silencing long non-coding RNA LINC01224 inhibits hepatocellular carcinoma progression via microRNA-330-5p-induced inhibition of CHEK1. Mol Ther Nucleic Acids. 2020;19:482–497. doi:10.1016/j.omtn.2019.10.007
   PubMedGoogle Scholar
• Bao J, Yu Y, Chen J, et al. MiR-126 negatively regulates PLK-4 to impact the development of hepatocellular carcinoma via ATR/CHEK1 pathway. Cell Death Dis. 2018;9(10):1045. doi:10.1038/s41419-018-1020-0
   PubMed Web of Science ®Google Scholar
• Fry AM, Schultz SJ, Bartek J, Nigg EA. Substrate specificity and cell cycle regulation of the Nek2 protein kinase, a potential human homolog of the mitotic regulator NIMA of Aspergillus nidulans. J Biol Chem. 1995;270(21):12899–12905. doi:10.1074/jbc.270.21.12899
   PubMed Web of Science ®Google Scholar
• Chang YY, Yen CJ, Chan SH, et al. NEK2 promotes hepatoma metastasis and serves as biomarker for high recurrence risk after hepatic resection. Ann Hepatol. 2018;17(5):843–856. doi:10.5604/01.3001.0012.3146
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang W, Wang Y, et al. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition. Oncol Rep. 2018;39(3):1023–1033. doi:10.3892/or.2018.6224
   PubMed Web of Science ®Google Scholar
• Faragher AJ, Fry AM. Nek2A kinase stimulates centrosome disjunction and is required for formation of bipolar mitotic spindles. Mol Biol Cell. 2003;14(7):2876–2889. doi:10.1091/mbc.e03-02-0108
   PubMed Web of Science ®Google Scholar
• Lee J, Gollahon L. Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple negative breast cancer cells. Int J Oncol. 2013;42(3):839–847. doi:10.3892/ijo.2013.1788
   PubMed Web of Science ®Google Scholar
• Hayward DG, Clarke RB, Faragher AJ, et al. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res. 2004;64(20):7370–7376. doi:10.1158/0008-5472.CAN-04-0960
   PubMed Web of Science ®Google Scholar
• Zeng X, Shaikh FY, Harrison MK, et al. The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene. 2010;29(36):5103–5112. doi:10.1038/onc.2010.253
   PubMed Web of Science ®Google Scholar
• Wu SM, Lin SL, Lee KY, et al. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression. Int J Cancer. 2017;140(7):1581–1596. doi:10.1002/ijc.30559
   PubMed Web of Science ®Google Scholar